ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 854,92
-1,20%
Dow Jones
44 531,58
-0,03%
DAX
21 428,24
-1,30%
Brent Oil
75,795
-0,73%
Bitcoin
101 123,72
3,50%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. HCW Biologics Inc (HCWB) Cours

HCW Biologics Inc

HCW Biologics Inc (HCWB)

NASDAQ
0,6467
0,3685
( 132,46% )
Mis à jour : 20:22:44
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
0,6467
Prix Achat
0,6407
Prix Vente
0,6463
Volume échangé
324 367 683
0,5567 Fourchette du Jour 1,03
0,2103 Plage de 52 semaines 2,52
Cap du marché
24,46M
Clôture Veille
0,2782
Ouverture
0,9786
Dernière Transaction
60
@
0.6421
Dernière heure de transaction
20:22:44
Volume financier
US$ 221 629 344
VWAP
0,683266
Volume moyen (3 m)
10 836 031
Actions en circulation
37 823 394
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-1,01
Bénéfice par action (BPA)
-0,66
Chiffre d'affairess
2,84M
Bénéfice net
-24,99M

À propos de HCW Biologics Inc

HCW Biologics Inc is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company believes age-related low-grade chronic inflammation is a signi... HCW Biologics Inc is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company believes age-related low-grade chronic inflammation is a significant contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.hcwbiologics.com
Siège social
Wilmington, Delaware, USA
Fondé
-
HCW Biologics Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker HCWB. Le dernier cours de clôture d'HCW Biologics était de US$0,28. Au cours de la dernière année, les actions de HCW Biologics ont été négociées dans une fourchette de prix de US$ 0,2103 à US$ 2,52.

HCW Biologics compte actuellement 37 823 394 actions en circulation. La capitalisation boursière d'HCW Biologics est de US$10,52 million. HCW Biologics a un ratio cours/bénéfice (ratio PE) de -1.01.

HCWB Dernières nouvelles

Plus de nouvelles

Form 8-K - Current report

il y a 7 heures
Edgar (US Regulatory)

HCW Biologics Granted FDA Clearance to Evaluate One of the Company’s Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial

MIRAMAR, Fla., Feb. 03, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCWB” or the “Company”) (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and...

il y a 7 heures
GlobeNewswire Inc.

HCW Biologics’ Founder and CEO to Address Opportunities and Challenges in Biomanufacturing for Cell and Gene Therapies During J.P. Morgan Week in San Francisco on January 15, 2025

MIRAMAR, Fla., Jan. 15, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCWB” or “HCW Biologics”), (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and...

15 Janvier 2025
GlobeNewswire Inc.

Form 8-K - Current report

23 Décembre 2024
Edgar (US Regulatory)

HCW Biologics Inc. Received NASDAQ Staff Determination Letter

Company Expected Notice for Continued Deficiency and Delist Letter from the Nasdaq Stock Market Company Intends to Request Hearing to Appeal in a Timely Manner MIRAMAR, Fla., Dec. 23, 2024...

23 Décembre 2024
GlobeNewswire Inc.

Form D - Notice of Exempt Offering of Securities

05 Décembre 2024
Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

22 Novembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

22 Novembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

20 Novembre 2024
Edgar (US Regulatory)

Form 424B2 - Prospectus [Rule 424(b)(2)]

20 Novembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.3247100.8385093170.3221.030.21035381580.28327948CS
40.236757.73170731710.411.030.21032608410.31919464CS
120.276774.78378378380.372.520.2103108360311.19124246CS
260.04677.783333333330.62.520.210348210171.18920355CS
52-0.4933-43.27192982461.142.520.210324196131.18916504CS
156-1.4833-69.63849765262.133.320.21038106091.20290774CS
260-6.8533-91.37733333337.57.510.21039132762.03939986CS

HCWB - Frequently Asked Questions (FAQ)

What is the current HCW Biologics share price?
The current share price of HCW Biologics is US$ 0,6467
How many HCW Biologics shares are in issue?
HCW Biologics has 37 823 394 shares in issue
What is the market cap of HCW Biologics?
The market capitalisation of HCW Biologics is USD 10,52M
What is the 1 year trading range for HCW Biologics share price?
HCW Biologics has traded in the range of US$ 0,2103 to US$ 2,52 during the past year
What is the PE ratio of HCW Biologics?
The price to earnings ratio of HCW Biologics is -1,01
What is the cash to sales ratio of HCW Biologics?
The cash to sales ratio of HCW Biologics is 8,92
What is the reporting currency for HCW Biologics?
HCW Biologics reports financial results in USD
What is the latest annual turnover for HCW Biologics?
The latest annual turnover of HCW Biologics is USD 2,84M
What is the latest annual profit for HCW Biologics?
The latest annual profit of HCW Biologics is USD -24,99M
What is the registered address of HCW Biologics?
The registered address for HCW Biologics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the HCW Biologics website address?
The website address for HCW Biologics is www.hcwbiologics.com
Which industry sector does HCW Biologics operate in?
HCW Biologics operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
HCWBHCW Biologics Inc
US$ 0,6622
(138,03%)
299,76M
IVVDInvivyd Inc
US$ 0,82
(129,24%)
333,44M
GHRSGH Research PLC
US$ 19,19
(81,04%)
8,05M
SGLYSingularity Future Technology Ltd
US$ 1,19
(72,59%)
43,55M
SOPASociety Pass Inc
US$ 2,5452
(67,45%)
98,65M
CYNCYNGN Inc
US$ 0,1201
(-55,52%)
53,05M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,1927
(-54,99%)
246,17M
PITAHeramba Electric PLC
US$ 0,49
(-45,56%)
984,54k
VIRXViracta Therapeutics Inc
US$ 0,0946
(-37,56%)
6,29M
YSXTYSX Tech Company Ltd
US$ 2,3001
(-33,14%)
196,56k
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0482
(33,52%)
382,19M
IVVDInvivyd Inc
US$ 0,82
(129,24%)
350,71M
UOKAMDJM Ltd
US$ 0,2143
(64,85%)
331,68M
HCWBHCW Biologics Inc
US$ 0,6622
(138,03%)
323,36M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,1927
(-54,99%)
279,16M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
HCWB
HCW Biologics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces